SGLT 2 Inhibitors

Explore clinical trials studying SGLT 2 Inhibitors. Study availability and eligibility vary by location and protocol.

7 public trials 2 recruiting studies

Refine in advanced search Browse all conditions

SGLT 2 Inhibitors trial results

Recruiting

Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid Cancer

NCT07703163

Conditions: SGLT 2 Inhibitors, Solid Tumor
Locations: West China Hospital Chengdu, Sichuan, China

View Trial Details

Recruiting

Effect of Empagliflozin on Inflammation

NCT07292909

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, CAD - Coronary Artery Disease, +12 more
Locations: Hotel Dieu de France Beirut, Lebanon

View Trial Details

Not yet recruiting

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients

NCT07186153

Conditions: SGLT 2 Inhibitors
Locations: Not specified

View Trial Details

Active, not recruiting

Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis

NCT07678203

Conditions: Autoimmune Diseases, Chronic Disease, Chronic Kidney Disease, +21 more
Locations: Nuevo Hospital Civil de Guadalajara "Dr. Juan I. Menchaca". Guadalajara, Jalisco, Mexico

View Trial Details

Active, not recruiting

Assessment of Retinal-Angio Findings In Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies

NCT07602348

Conditions: Cardiovascular Diseases, Diabetes Complications, Diabetes Mellitus, +15 more
Locations: 2nd Department of Ophthalmology, Attikon University Hospital, National and Kapodistrian University of Athens Athens, Attica, Greece

View Trial Details

Active, not recruiting

Efficacy and Safety of Dapagliflozin in Children With Proteinuria

NCT07204743

Conditions: Dapagliflozin (Forxiga), Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +11 more
Locations: Al Ahli hospital Hebron, Palestine, Palestinian Territories

View Trial Details

Completed

Novel Therapeutics and Endothelial Dysfunction in T1DM Patients

NCT05857085

Conditions: Arterial Stiffness, Autoimmune Diseases, Biomarkers, +14 more
Locations: General Hospital Celje Celje, Slovenia

View Trial Details

SGLT 2 Inhibitors

SGLT 2 Inhibitors trial results

Safety and Efficacy of Canagliflozin in Patients With Locally Advanced or Advanced Solid Cancer

Effect of Empagliflozin on Inflammation

Effect of Sodium Glucose Co-transporter 2 Inhibitors on Left Atrial Remodeling in Diabetic Patients

Dapagliflozin to Reduce the Decline in Renal Function in Patients Newly Diagnosed With Lupus Nephritis

Assessment of Retinal-Angio Findings In Patients With Diabetes Type II Treated With Novel Antidiabetic Therapies

Efficacy and Safety of Dapagliflozin in Children With Proteinuria

Novel Therapeutics and Endothelial Dysfunction in T1DM Patients

Related conditions